| Pharmaceutical Information |
| Drug Name |
Cortisone |
| Drug ID |
BADD_D00532 |
| Description |
A naturally occurring glucocorticoid. It has been used in replacement therapy for adrenal insufficiency and as an anti-inflammatory agent. Cortisone itself is inactive. It is converted in the liver to the active metabolite hydrocortisone. (From Martindale, The Extra Pharmacopoeia, 30th ed, p726) |
| Indications and Usage |
Not Available |
| Marketing Status |
experimental |
| ATC Code |
H02AB10; S01BA03 |
| DrugBank ID |
DB14681
|
| KEGG ID |
D07749
|
| MeSH ID |
D003348
|
| PubChem ID |
222786
|
| TTD Drug ID |
D0IX6I
|
| NDC Product Code |
Not Available |
| UNII |
V27W9254FZ
|
| Synonyms |
Cortisone | Cortisone Acetate | 17-Hydroxy-3,11,20-trioxopregn-4-en-21-yl acetate | Cortone Acetate | Adreson |
|
| Chemical Information |
| Molecular Formula |
C21H28O5 |
| CAS Registry Number |
53-06-5 |
| SMILES |
CC12CCC(=O)C=C1CCC3C2C(=O)CC4(C3CCC4(C(=O)CO)O)C |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
